Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K/A
 
(Amendment No. 1)
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 15, 2007
 
BIOANALYTICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)

Indiana
  
0-23357
 
35-1345024
(State or other jurisdiction of incorporation or organization)
  
(Commission File Number)
  
(I.R.S. Employer Identification No.)


2701 KENT AVENUE
WEST LAFAYETTE, INDIANA
  
 
47906-1382
(Address of principal executive offices)
  
(Zip Code)

Registrant's telephone number, including area code: (765) 463-4527


Explanatory Note: This Amendment No. 1 amends the Current Report on Form 8-K of Bioanalytical Systems, Inc. (the "Company") filed November 16, 2007, reporting under Item 8.01 that the Company had elected a new Chairman of the Board. This Amendment No. 1 amends the Current Report on Form 8-K filed November 16, 2007 to replace the Date of Report. As originally filed, the Date of Report was incorrectly listed as November 6, 2007. The Date of Report has been corrected to be November 15, 2007. The disclosures included under Item 8.01 of this Amendment No. 1 and attached hereto as Exhibit 99.1 are the same as the disclosures included under Item 8.01 of the Current Report on Form 8-K filed November 16, 2007 and attached thereto as Exhibit 99.1.

Item 8.01.
Other Events.
 
On November 15, 2007, the Board of Directors of Bioanalytical Systems, Inc. (the "Company") elected William B. Baitinger to be Chairman of the Board. Mr. Baitinger has served as a director of the Company since 1979.

On November 16, 2007, the Company issued a press release announcing Mr. Baitinger's election. The press release is attached hereto as Exhibit 99.1.

Item 9.01.
Financial Statements and Exhibits.
 
(a)
Not applicable.
 
(b)
Not applicable.
 
(c)
Not applicable.
 
(d)
Exhibits.
 
99.1
Press Release dated November 16, 2007.
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  Bioanalytical Systems, Inc.
 
 		  
 		  
 
Date: November 21, 2007  By:   /s/ Michael R. Cox 
 
Michael R. Cox
 
Vice President, Finance and Administration,
and Chief Financial Officer 
 

Exhibit No.
Description

99.1
Press Release dated November 16, 2007.